| 0 (0%) | 09-27 09:34 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 74.81 |
1-year : | 77.39 |
| Resists | First : | 64.05 |
Second : | 66.26 |
| Pivot price | 63.01 |
|||
| Supports | First : | 60.49 |
Second : | 50.33 |
| MAs | MA(5) : | 61.78 |
MA(20) : | 63.38 |
| MA(100) : | 59.35 |
MA(250) : | 66.99 |
|
| MACD | MACD : | -0.1 |
Signal : | 0.4 |
| %K %D | K(14,3) : | 13.5 |
D(3) : | 9.4 |
| RSI | RSI(14): 48.3 |
|||
| 52-week | High : | 86.48 | Low : | 49.54 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ MTX ] has closed above bottom band by 31.2%. Bollinger Bands are 39.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 62.5 - 62.91 | 62.91 - 63.28 |
| Low: | 59.69 - 60.21 | 60.21 - 60.69 |
| Close: | 61.37 - 62.21 | 62.21 - 62.96 |
Thu, 25 Sep 2025
Minerals Technologies (MTI) Q3 2025 Earnings: Conference Call Details and Webcast Access - Stock Titan
Fri, 29 Aug 2025
Evaluation of a Pharmacist-Driven High-Dose MTX Monitoring Protocol - Journal of Hematology Oncology Pharmacy
Sat, 09 Aug 2025
A RuneScape Reckoning: CEO Admits MTX Harm, Promises Change - MMORPG.com
Thu, 17 Jul 2025
Is the Options Market Predicting a Spike in MTX Stock? - Yahoo Finance
Sat, 07 Jun 2025
Overcoming drug resistance in osteosarcoma with MTX-CuB-NLC: An in vitro and in vivo study - ScienceDirect.com
Fri, 06 Jun 2025
Mediar commences dosing in Phase II trial of MTX-463 for IPF - Clinical Trials Arena
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 31 (M) |
| Shares Float | 31 (M) |
| Held by Insiders | 1.1 (%) |
| Held by Institutions | 102.1 (%) |
| Shares Short | 495 (K) |
| Shares Short P.Month | 601 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 52.72 |
| Profit Margin | 0.1 % |
| Operating Margin | 14.9 % |
| Return on Assets (ttm) | 4.8 % |
| Return on Equity (ttm) | 0.3 % |
| Qtrly Rev. Growth | -2.3 % |
| Gross Profit (p.s.) | 16.71 |
| Sales Per Share | 65.64 |
| EBITDA (p.s.) | 11.42 |
| Qtrly Earnings Growth | 135.5 % |
| Operating Cash Flow | 189 (M) |
| Levered Free Cash Flow | 296 (M) |
| PE Ratio | 6219 |
| PEG Ratio | 0 |
| Price to Book value | 1.17 |
| Price to Sales | 0.94 |
| Price to Cash Flow | 10.33 |
| Dividend | 0.1 |
| Forward Dividend | 0 |
| Dividend Yield | 0.1% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|